Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

[1]  A. Dagnault,et al.  Breast-conserving therapy after previous irradiation for lymphoma , 2010, Breast Cancer Research and Treatment.

[2]  L. Livi,et al.  Breast Cancer Following Hodgkin’s Disease: The Experience of the University of Florence , 2010, The breast journal.

[3]  Melissa M. Hudson,et al.  Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer , 2010, Annals of Internal Medicine.

[4]  M. J. van de Vijver,et al.  Radiation-associated breast tumors display a distinct gene expression profile. , 2010, International journal of radiation oncology, biology, physics.

[5]  Zuofeng Li,et al.  Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[6]  A. Broeks,et al.  Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Howell,et al.  The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage , 2009, British Journal of Cancer.

[8]  A. Niemierko,et al.  Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis , 2009, Radiation oncology.

[9]  L. Harrison,et al.  Partial Breast Brachytherapy as the Primary Treatment for Breast Cancer Diagnosed After Mantle Radiation Therapy for Hodgkin's Disease , 2009, American journal of clinical oncology.

[10]  Kevin C Oeffinger,et al.  Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. , 2009, JAMA.

[11]  A. Taghian,et al.  Breast cancer after treatment of Hodgkin's lymphoma: general review. , 2008, International journal of radiation oncology, biology, physics.

[12]  M. Hudson,et al.  Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. , 2008, International journal of radiation oncology, biology, physics.

[13]  E. Noordijk,et al.  The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  A. Taghian,et al.  Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma , 2008, Nature Clinical Practice Oncology.

[15]  L. D. Stegman,et al.  Long-term clinical outcomes of whole-breast irradiation delivered in the prone position. , 2007, International journal of radiation oncology, biology, physics.

[16]  J. Klijn,et al.  Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study , 2007, Breast Cancer Research.

[17]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[18]  E. Noordijk,et al.  Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  A. Luini,et al.  A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT) , 2005, Breast Cancer Research.

[20]  J. Vilcoq,et al.  Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation. , 2005, International journal of radiation oncology, biology, physics.

[21]  Dirk Hasenclever,et al.  Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Yahalom.  Breast cancer after Hodgkin disease: hope for a safer cure. , 2003, JAMA.

[23]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[24]  D. Nelson,et al.  Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. , 2003, Mayo Clinic proceedings.

[25]  A. Vincent-Salomon,et al.  Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS * Study , 2003, Histopathology.

[26]  J. Friedberg,et al.  Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. , 2002, Blood.

[27]  M. Stovall,et al.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Borel,et al.  Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  M. Deutsch,et al.  Lumpectomy and Breast Irradiation for Breast Cancer Arising After Previous Radiotherapy for Hodgkin’s Disease or Lymphoma , 2001, American journal of clinical oncology.

[30]  I. Aref,et al.  Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. , 2000, The British journal of radiology.

[31]  S. Jeffrey,et al.  Management of breast cancer after Hodgkin's disease. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  P. Goss,et al.  Breast Cancer in Women following Supradiaphragmatic Irradiation for Hodgkin’s Disease , 1999, Oncology.

[33]  H. Joensuu,et al.  Second cancer among long-term survivors from Hodgkin's disease. , 1998, International journal of radiation oncology, biology, physics.

[34]  J. Chavaudra,et al.  Dernières recommandations de l'ICRU pour la prescription, l'enregistrement et le compte rendu de la radiothérapie externe , 1998 .

[35]  K. Lamborn,et al.  Second cancers following pediatric Hodgkin's disease. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  J. Tortochaux,et al.  Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas , 1997 .

[37]  C. Willett,et al.  High risk of breast carcinoma after irradiation of young women with Hodgkin's disease , 1997, Cancer.

[38]  J. Bogart,et al.  Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. , 1997, International journal of radiation oncology, biology, physics.

[39]  A Kreuger,et al.  Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  L. Robison,et al.  Breast cancer and other second neoplasms after childhood Hodgkin's disease. , 1996, The New England journal of medicine.

[41]  A. Hagenbeek,et al.  Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  M Tubiana,et al.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  H. Kaplan,et al.  The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. , 1984, International journal of radiation oncology, biology, physics.

[45]  S. Rosenberg,et al.  The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.

[46]  H. Kaplan.  The radical radiotherapy of regionally localized Hodgkin's disease. , 1962, Radiology.

[47]  A. Taghian,et al.  Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. , 2009, International journal of radiation oncology, biology, physics.

[48]  S. Singletary,et al.  Revision of breast cancer staging: the 6th edition of the TNM Classification. , 2003, Seminars in surgical oncology.

[49]  F. Collin,et al.  [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]. , 1996, Annales de pathologie.